Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Defective in cullin neddylation 1 domain containing 2 (DCUN1D2) is a member of the DCN1-like protein family, which serves as a cofactor stimulating the neddylation of cullin components of SCF-type E3 ubiquitin ligase complexes. DCUN1D2 contains two conserved domains: a C-terminal PONY domain essential for neddylation activation, and a predicted N-terminal ubiquitin-associated (UBA) domain mediating direct ubiquitin interaction[1][2][3]. It can bind cullin family proteins and positively regulate protein neddylation, thereby modulating activity of cullin-RING ligase complexes central to targeted protein ubiquitination and proteasomal degradation[2][3][5]. DCUN1D2 localizes to both nucleus and cytoplasm and is broadly expressed, with higher expression in specific tissues such as brain, muscle, and testis (specifically in spermatogonia and spermatocytes)[1][3][5]. While knockout studies in mice indicate DCUN1D2 is not essential for spermatogenesis or male fertility due to functional redundancy with other DCNL family members[1], perturbation of neddylation pathways (including those regulated by DCN1-like proteins) is relevant for cancer and possibly other diseases[3][5]. There are no known drugs directly targeting DCUN1D2, nor identified patient biomarkers or notable therapeutic safety concerns at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Defective in cullin neddylation 1 domain containing 2 (DCUN1D2).